3D Bio-Printing Market: Future Of Organ Implants

By Goldstein Market Intelligence || 2018-02-03 2:35:01 AM

3D Bio-Printing Market: Future Of Organ Implants

According to Goldstein Research, “Rising need for human organs for transplants and growing applications in pharmaceutical industry such as regenerative medicines and drug discovery among others is driving the growth of 3D Bioprinting market." 3D Bioprinting showcases viable opportunity to generate patient-specific organs and tissues for the development of accurate and complete personalized treatments. Moreover, 3D Bioprinting is an important innovation, revolutionizing medicines from prosthetics and tissue engineering, to customized medicines that can be manufactured on demand.

Global 3D Bioprinting Market Outlook 2024”

The global 3D Bioprinting market is segmented based on technology and by applications. Application segment is further bifurcated into pharmaceutical, tissue and organ regeneration, bones and 3D cell culture. In 2016, healthcare sector accounted for the highest revenue share of more than 40% market share owing to the development of tissues and prosthetics along with pills. Further, the segment is anticipated to dominate the market during the forecast period with over 50% market share in 2024.

The global 3D Bioprinting market accounted for USD 0.460 billion in 2016 and is set to be worth a staggering USD 1.3 billion by the end of forecast period i.e. 2024. Further the market is anticipated to expand at compound annual growth rate of 13.8% over the forecast period i.e. 2016-2024.

The global 3D printing market valued worth USD 4 billion market in 2016 that includes hardware, materials and services. According to Goldstein Research, North America and Europe dominate the global 3D Bioprinting market with approximately 60% market share. However, it is expected that Asia Pacific region is poised to take lead in 3D Bioprinting technology in future. Asia Pacific is the key region for the potential adoption of 3D Bioprinting technology, dominated by the South Korea, Japan and China, which currently contributes to the 21% of the share in global 3D Bioprinting market.

Organ Implant Shortage: Opportunity

The world is facing the huge shortage of organs available for lifesaving transplants. For instance, in U.K an individual have to wait an average of 944 days for a kidney transplant. There is similar shortage of liver, lungs and other organs. The shortage of transplant tissues and organs is estimated to be the major cause for the death in America with around 900,000 deaths a years or one third of all deaths in the U.S. These rising number of deaths can be prevented or delayed by the printed or engineered tissue transplants, with the growing demand the growth opportunity for 3D Bioprinting technology is endless.

“Global 3D Bioprinting Market Outlook 2024” contains detailed overview of the global 3D Bioprinting market in terms of market segmentation by technology type and by applications.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.

Global 3D Bioprinting Market Report also provides competitive outlook of some of the major players which includes profiling of companies such as Organao, BioBots, Cellink, Poietis, EnvisionTec Gmbh, Nano3D Biosciences Inc., Cyfuse Biomedical etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.

Overall, the report represents comprehensive synopsis on the global 3D Bioprinting market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Send Us Sample Request

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Backed up by reliable research and impactful statistics, our business solutions empower our clients to grow at a fast pace despite unsettling fluctuations in the market. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.